Cellyan Biotechnology Co., Ltd (HKPD) vs IM Cannabis Corp. (IMCC)
A side-by-side comparison of Cellyan Biotechnology Co., Ltd and IM Cannabis Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HKPD
Cellyan Biotechnology Co., Ltd
$0.10HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
IMCC
IM Cannabis Corp.
$1.89HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — HKPD vs IMCC
growth of $100 · dividends reinvested · last 2yHKPD -96.3% (-80.8%/yr)IMCC -97.3% (-83.7%/yr)HKPD compounded faster over this window
HKPD IMCC
HKPD vs IMCC: by the numbers
- •IMCC is the larger company ($1M vs $1M market cap).
- •Both run net losses; HKPD's is the smaller (-8.46% vs -38.08% net margin).
Metrics side by side
Valuation
| Metric | HKPD | IMCC |
|---|---|---|
| P/S ratio | N/A | 0.04 |
| P/B ratio | 0.11 | N/A |
Profitability
| Metric | HKPD | IMCC |
|---|---|---|
| Gross margin | 10.32% | 13.74% |
| Operating margin | -7.41% | -25.95% |
| Net margin | -8.46% | -38.08% |
| ROE | -11.85% | N/A |
| ROIC | -9.45% | -128.95% |
Growth (annualized)
| Metric | HKPD | IMCC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 4.19% |
| Total return CAGR (5Y) | N/A | -80.08% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.